Testing CSF1R brain disease after stem cell transplant
Part of Brain & nervous system clinical trials.
This study looks at how CSF1R-related leukoencephalopathy (a genetic brain condition) behaves after a stem cell transplant. It may help doctors understand expected brain and walking changes after treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- You have genetic test confirmation of a CSF1R gene mutation.
- You have been diagnosed with CSF1R-related leukoencephalopathy.
- You are planning to have a stem cell transplant (HSCT).
- You can complete brain/mental testing and do so reliably (no major issues that would interfere, like severe hearing or vision problems).
- You can have MRI scans (no implants or devices that make MRI unsafe).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at biomarkers (biological signs in your blood) in people with immune-mediated neurological diseases. It compares those getting a stem cell transplant to those on high-efficacy MS treatments to understand how these therapies work.
This study follows people getting a stem cell transplant to watch for lung problems, like infections or other lung diseases, that can happen after the transplant. The goal is to catch these issues early.
This study looks at how often liver problems happen and how they develop in people being evaluated for a stem cell transplant. It may help doctors predict and better manage liver complications during and after transplant care.
This study checks how children who had a stem cell transplant for a primary immune deficiency are doing emotionally and mentally, at least 2 years after the transplant. It helps us understand the long-term effects of this treatment on children's health and development.
This study looks at how your body processes medications after a stem cell transplant from a donor. It aims to find the best way to test your genes to improve future treatments.
This trial is for people with high-risk acute lymphoblastic leukemia who are getting a stem cell transplant from a family donor. After transplant, you'd receive a treatment that combines specially designed immune cells (CAR T cells) that target your leukemia, plus a vaccine that helps those cells work better.
Hear when a new Hematopoietic Stem Cell Transplantation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.